Nondepolarizing neuromuscular blocking agent

This page covers all Nondepolarizing neuromuscular blocking agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Cholinergic receptor sites on motor end-plate, Cholinergic receptors at the motor end-plate.

Targets

Cholinergic receptor sites on motor end-plate · Cholinergic receptors at the motor end-plate

Marketed (2)

• Tracrium Preservative Free · Pfizer Inc.
  Nondepolarizing skeletal muscle relaxant that competitively antagonizes acetylcholine at motor end-plate cholinergic receptors.
• Rocuronium · Merck & Co. · Neuroscience
  Rocuronium bromide competes for cholinergic receptors at the motor end-plate, antagonized by acetylcholinesterase inhibitors.